EYENOVIA, INC. Contracts & Agreements

Warrant Amendment Agreement, dated August 24, 2023 (Filed With SEC on August 29, 2023)

Securities Purchase Agreement, dated August 24, 2023 (Filed With SEC on August 29, 2023)

Form of Pre-Funded Warrant (Filed With SEC on August 29, 2023)

Form of Warrant (Filed With SEC on August 29, 2023)

Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan, as Amended (Filed With SEC on June 27, 2023)

Description of Securities (Filed With SEC on March 31, 2023)

Loan and Security Agreement, dated November 22, 2022, by among Eyenovia, Inc., Avenue Capital Management II, L.P., Avenue Venture Opportunities Fund, L.P. and Avenue Venture... (Filed With SEC on March 31, 2023)

Supplement to the Loan and Security Agreement, dated November 22, 2022, by among Eyenovia, Inc., Avenue Capital Management II, L.P., Avenue Venture Opportunities Fund, L.P. and... (Filed With SEC on March 31, 2023)

Subscription Agreement, dated November 22, 2022, by and among Eyenovia, Inc., Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P (Filed With SEC on March 31, 2023)

Employment Agreement, dated December 19, 2022, by and between Eyenovia, Inc. and Bren Kern (Filed With SEC on March 31, 2023)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on November 14, 2022)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 11, 2022)

Executive Chair Agreement, dated August 1, 2022, by and between, Eyenovia, Inc. and Tsontcho Ianchulev (Filed With SEC on August 11, 2022)

Employment Agreement, dated July 26, 2022, by and between Eyenovia, Inc, and Michael Rowe (Filed With SEC on August 11, 2022)

Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan (Filed With SEC on June 17, 2022)

Third Amendment to Loan and Security Agreement, dated as of May 6, 2022, by and between Eyenovia, Inc. and Silicon Valley Bank (Filed With SEC on May 12, 2022)

Director Compensation Policy (Filed With SEC on March 30, 2022)

Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and Michael Rowe (Filed With SEC on March 30, 2022)

Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and John Gandolfo (Filed With SEC on March 30, 2022)

Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and Tsontcho Ianchulev (Filed With SEC on March 30, 2022)

Description of Securities (Filed With SEC on March 30, 2022)

Form of Purchase Agreement between the Company and the Purchaser, dated March 3, 2022 (Filed With SEC on March 9, 2022)

Form of Warrant (Filed With SEC on March 9, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 9, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 7, 2022)

Form of Warrant (Filed With SEC on March 7, 2022)

Form of Purchase Agreement between the Company and the Purchaser, dated March 3, 2022 (Filed With SEC on March 7, 2022)

Settlement Agreement, dated as of February 4, 2022 (Filed With SEC on February 7, 2022)

Waiver Agreement, dated as of November 30, 2021, by and between the Company and SVB (Filed With SEC on December 3, 2021)

Amendment 1 to the License Agreement between Eyenovia, Inc. and Arctic Vision (Hong Kong) Limited, dated September 14, 2021 (Filed With SEC on November 12, 2021)

Amendment 2 to the Exclusive License Agreement between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., effective as of May 2021 (Filed With SEC on November 12, 2021)

First Amendment to Loan and Security Agreement between Eyenovia, Inc. and Silicon Valley Bank, dated September 29, 2021 (Filed With SEC on November 12, 2021)

Amended and Restated 2018 Omnibus Stock Incentive Plan, As Amended (Filed With SEC on August 12, 2021)

Sales Agreement, dated as of May 14, 2021, between Eyenovia, Inc. and SVB Leerink LLC (Filed With SEC on May 14, 2021)

Form of Warrant issued by the Company to Silicon Valley Bank (Filed With SEC on May 10, 2021)

Loan and Security Agreement, dated as of May 7, 2021, by and between the Company and Silicon Valley Bank (Filed With SEC on May 10, 2021)

Description of Securities (Filed With SEC on March 30, 2021)

Amendment to Executive Employment Agreement, dated February 1, 2021, by and between the Company and Michael M. Rowe (Filed With SEC on February 3, 2021)

License Agreement by and between Eyenovia, Inc. and Bausch Health Ireland Limited, dated October 9, 2020 (Filed With SEC on October 13, 2020)

Underwriting Agreement, dated August 19, 2020, by and between Eyenovia, Inc. and William Blair & Company, L.L.C. as representative of the several underwriters named therein (Filed With SEC on August 21, 2020)

License Agreement by and between Eyenovia, Inc. and Artic Vision (Hong Kong) Limited, dated August 10, 2020 (Filed With SEC on August 14, 2020)

Letter Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated August 10, 2020 (Filed With SEC on August 14, 2020)

Amendment to the Exclusive License Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated April 8, 2020 (Filed With SEC on August 14, 2020)

Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan (Filed With SEC on July 2, 2020)

Promissory Note and Agreement dated May 3, 2020 (Filed With SEC on May 8, 2020)

Description of Securities (Filed With SEC on March 30, 2020)

Form of Class B Warrant issued on March 24, 2020 (Filed With SEC on March 25, 2020)

Form of Class A Warrant issued on March 24, 2020 (Filed With SEC on March 25, 2020)

Securities Purchase Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein (Filed With SEC on March 25, 2020)

Registration Rights Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein (Filed With SEC on March 25, 2020)

Underwriting Agreement, dated July 11, 2019, by and among Eyenovia, Inc. and Oppenheimer & Co. Inc., as representative of the several underwriters named therein (Filed With SEC on July 15, 2019)

Eyenovia, Inc. 2018 Omnibus Stock Incentive Plan, as amended (Filed With SEC on June 12, 2019)

Executive Employment Agreement, dated February 15, 2019, by and between the Company and Luke Clauson (Filed With SEC on February 19, 2019)

Executive Employment Agreement, dated February 15, 2019, by and between the Company and Michael Rowe (Filed With SEC on February 19, 2019)

Executive Employment Agreement, dated February 15, 2019, by and between the Company and Jennifer Clasby (Filed With SEC on February 19, 2019)

Form of Nondisclosure, Assignment of Inventions and Noncompetition Agreement (Filed With SEC on February 19, 2019)

Executive Employment Agreement, dated February 15, 2019, by and between the Company and John Gandolfo (Filed With SEC on February 19, 2019)

Executive Employment Agreement, dated February 15, 2019, by and between the Company and Tsontcho Ianchulev (Filed With SEC on February 19, 2019)

Underwriting Agreement, dated December 19, 2018, by and between Eyenovia, Inc. and National Securities Corporation (Filed With SEC on December 21, 2018)

Form of Underwriting Agreement (Filed With SEC on December 12, 2018)

Form of Restricted Stock Award Agreement (Filed With SEC on June 14, 2018)

Eyenovia, Inc. 2018 Omnibus Stock Incentive Plan (Filed With SEC on June 14, 2018)

Form of Notice of Stock Option Grant and Award Agreement (Filed With SEC on June 14, 2018)

Underwriting Agreement between the Company and Ladenburg Thalmann & Co. Inc. and Roth Capital Partners, LLC (Filed With SEC on January 29, 2018)

Form of Underwriting Agreement (Filed With SEC on January 9, 2018)

Engagement Letter for Professional Services, dated December 18, 2017, between Eyenovia, Inc. and John Gandolfo (Filed With SEC on January 9, 2018)

Engagement Letter for Professional Services, dated July 6, 2017, between Eyenovia, Inc. and Dr. Curt LaBelle (Filed With SEC on December 19, 2017)

Amended and Restated Investors Rights Agreement, dated September 27, 2017, between Eyenovia, Inc. and investors party thereto (Filed With SEC on December 19, 2017)

Amended and Restated Right of First Refusal and Co-Sale Agreement, dated September 27 2017, between Eyenovia, Inc. and investors party thereto (Filed With SEC on December 19, 2017)

Amended and Restated Voting Agreement, dated September 27, 2017, between Eyenovia, Inc. and investors party thereto (Filed With SEC on December 19, 2017)

Correction Letter, dated November 8, 2017, between Eyenovia, Inc. and Dr. Tsontcho Ianchulev (Filed With SEC on December 19, 2017)

Master Consulting Services Agreement, dated November 4, 2014, between Eyenovia, Inc. and Private Medical Equity, Inc (Filed With SEC on December 19, 2017)

Master Consulting Services Agreement, dated November 4, 2014, between Eyenovia, Inc. and Point Guard Partners, LLC (Filed With SEC on December 19, 2017)

Engagement Letter and Offer of Employment, dated July 6, 2017, between Eyenovia, Inc. and Jennifer G. Clasby (Filed With SEC on December 19, 2017)

Engagement Letter and Offer of Employment, dated July 6, 2017, between Eyenovia, Inc. and Luke Clauson (Filed With SEC on December 19, 2017)

Engagement Letter and Offer of Employment, dated July 6, 2017, between Eyenovia, Inc. and Dr. Tsontcho Ianchulev (Filed With SEC on December 19, 2017)

Exclusive License Agreement, dated March 18, 2015, between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd (Filed With SEC on December 19, 2017)